Glioblastoma has long endured as one of medicine's most humbling adversaries, not merely because of its lethality but because the brain's own protective architecture keeps help from arriving. Researchers at Ohio State University have now turned that architecture against the tumor itself, engineering sugar-coated nanoparticles that exploit the cancer's metabolic hunger to slip past the blood-brain barrier and restore a silenced tumor-suppressing gene. In mouse models, the approach extended median survival by half, with no detectable harm to surrounding organs — a quiet but significant signal th